ALBEMARLE CORP (ALB)
US0126531013 - Common Stock
We assign a fundamental rating of 3 out of 10 to ALB. ALB was compared to 83 industry peers in the Chemicals industry. ALB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALB is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ALB was profitable.
In the past year ALB had a positive cash flow from operations.
ALB had positive earnings in each of the past 5 years.
In the past 5 years ALB always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ALB (-11.27%) is worse than 85.54% of its industry peers.
ALB has a worse Return On Equity (-19.21%) than 81.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.27% | ||
| ROE | -19.21% | ||
| ROIC | N/A |
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALB's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ALB has declined.
The Profit Margin and Operating Margin and Gross Margin are not available for ALB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALB has more shares outstanding
The number of shares outstanding for ALB has been increased compared to 5 years ago.
ALB has a worse debt/assets ratio than last year.
2.2 Solvency
ALB has an Altman-Z score of 1.64. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
ALB has a Altman-Z score of 1.64. This is in the lower half of the industry: ALB underperforms 60.24% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that ALB is not too dependend on debt financing.
ALB has a better Debt to Equity ratio (0.35) than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.64 |
ROIC/WACCN/A
WACC7.27%
2.3 Liquidity
ALB has a Current Ratio of 2.44. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.44, ALB is doing good in the industry, outperforming 60.24% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that ALB should not have too much problems paying its short term obligations.
ALB has a better Quick ratio (1.58) than 61.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.58 |
3. Growth
3.1 Past
The earnings per share for ALB have decreased strongly by -97.93% in the last year.
Measured over the past years, ALB shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.24% on average per year.
The Revenue for ALB has decreased by -34.20% in the past year. This is quite bad
The Revenue has been growing by 23.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%
3.2 Future
The Earnings Per Share is expected to decrease by -2.38% on average over the next years.
Based on estimates for the next years, ALB will show a small growth in Revenue. The Revenue will grow by 2.39% on average per year.
EPS Next Y-108.29%
EPS Next 2Y-78.6%
EPS Next 3Y-42.4%
EPS Next 5Y-2.38%
Revenue Next Year-41.46%
Revenue Next 2Y-23.18%
Revenue Next 3Y-11.16%
Revenue Next 5Y2.39%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 150.90, ALB can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ALB is valued a bit more expensive than the industry average as 69.88% of the companies are valued more cheaply.
ALB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.72.
A Price/Forward Earnings ratio of 88.89 indicates a quite expensive valuation of ALB.
Based on the Price/Forward Earnings ratio, ALB is valued a bit more expensive than the industry average as 77.11% of the companies are valued more cheaply.
ALB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 150.9 | ||
| Fwd PE | 88.89 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALB's earnings are expected to decrease with -42.40% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)4.68
EPS Next 2Y-78.6%
EPS Next 3Y-42.4%
5. Dividend
5.1 Amount
ALB has a Yearly Dividend Yield of 1.57%.
ALB's Dividend Yield is comparable with the industry average which is at 3.14.
ALB's Dividend Yield is slightly below the S&P500 average, which is at 2.24.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
5.2 History
The dividend of ALB has a limited annual growth rate of 3.69%.
ALB has paid a dividend for at least 10 years, which is a reliable track record.
ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.69%
Div Incr Years30
Div Non Decr Years30
5.3 Sustainability
ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-13.67%
EPS Next 2Y-78.6%
EPS Next 3Y-42.4%
ALBEMARLE CORP
NYSE:ALB (12/18/2024, 8:04:00 PM)
After market: 90.85 +0.31 (+0.34%)90.54
-7.01 (-7.19%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners90.4%
Inst Owner Change-1.12%
Ins Owners0.48%
Ins Owner Change1.98%
Market Cap10.64B
Analysts69.03
Price Target113.71 (25.59%)
Short Float %10.85%
Short Ratio5.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.57% |
Dividend Growth(5Y)3.69%
DP-13.67%
Div Incr Years30
Div Non Decr Years30
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-249.28%
Max EPS beat(2)-90.28%
EPS beat(4)1
Avg EPS beat(4)-65.31%
Min EPS beat(4)-249.28%
Max EPS beat(4)81.63%
EPS beat(8)4
Avg EPS beat(8)-22.65%
EPS beat(12)8
Avg EPS beat(12)-10.42%
EPS beat(16)12
Avg EPS beat(16)-2.63%
Revenue beat(2)1
Avg Revenue beat(2)1.81%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)5.88%
Revenue beat(4)3
Avg Revenue beat(4)3.35%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)6.99%
Revenue beat(8)3
Avg Revenue beat(8)-0.88%
Revenue beat(12)4
Avg Revenue beat(12)-0.81%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)1.12%
PT rev (3m)2.13%
EPS NQ rev (1m)-43.68%
EPS NQ rev (3m)-165.79%
EPS NY rev (1m)-194.43%
EPS NY rev (3m)-670.64%
Revenue NQ rev (1m)-5.05%
Revenue NQ rev (3m)-20.68%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)-1.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 150.9 | ||
| Fwd PE | 88.89 | ||
| P/S | 1.64 | ||
| P/FCF | N/A | ||
| P/OCF | 17.64 | ||
| P/B | 1.04 | ||
| P/tB | 1.27 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.6
EY0.66%
EPS(NY)1.02
Fwd EY1.13%
FCF(TTM)-12
FCFYN/A
OCF(TTM)5.13
OCFY5.67%
SpS55.32
BVpS87.12
TBVpS71.1
PEG (NY)N/A
PEG (5Y)4.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.27% | ||
| ROE | -19.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)9.05%
ROA(5y)7.23%
ROE(3y)17.54%
ROE(5y)15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.57%
ROCE(5y)8.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-35%
OM growth 5Y-26.28%
PM growth 3Y10.85%
PM growth 5Y-4.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 353.56% | ||
| Cap/Sales | 30.98% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.58 | ||
| Altman-Z | 1.64 |
F-Score3
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)431.6%
Cap/Depr(5y)412.07%
Cap/Sales(3y)22.75%
Cap/Sales(5y)23.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.93%
EPS 3Y75.42%
EPS 5Y32.24%
EPS Q2Q%-156.57%
EPS Next Y-108.29%
EPS Next 2Y-78.6%
EPS Next 3Y-42.4%
EPS Next 5Y-2.38%
Revenue 1Y (TTM)-34.2%
Revenue growth 3Y45.4%
Revenue growth 5Y23.3%
Sales Q2Q%-41.37%
Revenue Next Year-41.46%
Revenue Next 2Y-23.18%
Revenue Next 3Y-11.16%
Revenue Next 5Y2.39%
EBIT growth 1Y-165.41%
EBIT growth 3Y-5.49%
EBIT growth 5Y-9.1%
EBIT Next Year-47.87%
EBIT Next 3Y-4.91%
EBIT Next 5Y19%
FCF growth 1Y-358.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.46%
OCF growth 3Y18.38%
OCF growth 5Y19.4%